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             A 75-year-old woman with paroxysmal atrial fibrillation (AF) experienced recurrent 
seizures at home. Holter monitoring (Figure 1) (each line 50 sec) showed repetitive runs of 
torsade de pointes (TdP), degenerating into ventricular fibrillation and ventricular tachycardia 
(VT). Abrupt asytole heralded end of electrical activity and life. Amazingly, 6 min after cardiac 
arrest a slow ventricular escape rhythm arose spontaneously without resuscitation. At baseline, 
repolarisation was markedly prolonged (QTc>660 msec) and ventricular bigeminy triggered 
short bursts of TdP after "long-short" sequences. No hypokalemia or renal dysfunction was 
present. Following intensive treatment (sedation, magnesium iv, acceleration of heart rate) the 
patient   recovered   without   neurological   deficit.   Except   left   ventricular   hypertrophy   and 
incomplete left bundle branch block the results of angiography, electrophysiological study and 
ajmaline test were normal. There was no family history of sudden death. Months ago a 
cardioversion attempt with ibutilide triggered polymorphic VT. Therapy with metoprolol (95 
mg/day) was discontinued due to poor efficacy of rhythm control. Thus, sotalol (240 mg/day) 
was initiated in-hospital without signs of QT prolongation within 4 days (QT 416, QTc 432 
msec). However, two weeks later the patient presented with an "idiosyncratic" proarrhythmic 
response to sotalol (IKr-blocking drug) and a life-threatening arrhythmia.1  There is growing 
evidence that drug-induced long QT syndrome (LQTS) may be due to "silent" mutations on LQT 
genes.2,3 Although not proven by molecular analysis, our case seems to resemble a subclinical, 
inherited form of LQTS that makes the patient vulnerable to the QT-prolonging effects of a 
variety of cardiac and noncardiac drugs. The concept of "repolarization reserve" suggests that 
any factor that impairs the repolarizing currents renders TdP very likely when IKr-blocking drugs 
are used. Avoiding torsadogenic drugs should basically prevent recurrence of TdP. However, an 
implantable cardioverter-defibrillator was placed for safety reasons.4  During a follow-up of 
more than two years a few non-sustained episodes occurred, the longest, a short-coupled 
polymorphic VT lasted for 25 beats resulting in a diverted shock.
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Figure 1: Holter tracing (each line 50 sec)
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